ISRCTN68624341进行中（未招募）未知
A multicentre, randomised, parallel-group study to compare the effectiveness of an early eye movement desensitisation and reprocessing group intervention with care as usual in preventing post-traumatic stress symptoms in women who have experienced a traumatic birth
niversity of Ulster0 个研究点目标入组 96 人开始时间: 2021年8月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women who have had a caesarean birth
- •2. Women who have experienced their birth as traumatic
- •3. Women who meet subclinical symptom criteria for PTSD under 33 on the impact of event scale
- •4. Aged over 18 years with the legal capacity to consent
- •5. Willingness and ability to attend three online intervention sessions
排除标准
- •1. Score over >35 on the Dissociative Experience Scale
- •2. Presence of severe psychiatric disorder such as psychosis, bipolar or active suicide risk
- •3. Women currently diagnosed with PTSD
- •4. Presence of severe medical conditions including traumatic brain injuries
- •5. Currently receiving psychological treatment
- •6. Drug or alcohol abuse
- •7. Overt dementia
- •8. Ongoing injected or oral corticosteroid treatment
- •9. Women who have absolutely no social and familial support
- •10. Women who are critically ill
研究者
相似试验
已完成
2 期
A multicenter, randomized, parallel-group study to assess the safety and efficacy of adhesion prevention device, BAX 602, in preventing adhesion of heart and great vessels to surroundings after placement of extracorporeal ventricular assist device (VAD)Patients undergoing open surgery for VAD placement to treat acute circulatory failure, who fulfill all the inclusion and exclusion criteria at the time of enrollment will be enrolled as eligible patients.JPRN-UMIN000038998ational Cerebral and Cardiovascular Center30
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidseiomyomaMedDRA version: 21.1Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10016628Term: FibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10022794Term: Intramural leiomyoma of uterusSystem Organ Class: 100000004864EUCTR2016-002855-48-SKBayer AG766
已完成
3 期
A randomized, parallel-group, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroidsleiomyomauterine fibroids10013326NL-OMON48550Bayer18
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidseiomyomaMedDRA version: 21.1Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10016628Term: FibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10022794Term: Intramural leiomyoma of uterusSystem Organ Class: 100000004864EUCTR2016-002855-48-DEBayer AG1,200
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidsEUCTR2016-002855-48-NLBayer AG1,200